Juan J Andino, Navid Leelani, Ryoko Sato, Young Shin, Sirikan Rojanasarot, Thiago Furtado, Helen L Bernie, Petar Bajic, Carolyn A Salter, Joshua A Halpern
{"title":"Association between surgeon procedure volume and reoperation rates for penile prosthesis implantation.","authors":"Juan J Andino, Navid Leelani, Ryoko Sato, Young Shin, Sirikan Rojanasarot, Thiago Furtado, Helen L Bernie, Petar Bajic, Carolyn A Salter, Joshua A Halpern","doi":"10.1093/jsxmed/qdaf064","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prior studies have examined patient-specific predictors of reoperation following penile prosthesis (PP) insertion at the local and regional level, but little is known about patient factors and volume-outcome relationships at the national level.</p><p><strong>Aim: </strong>To assess the impact of patient characteristics and surgeon volume on reoperation rates following PP placement in a Medicare population.</p><p><strong>Methods: </strong>We utilized the 100% Medicare Standard Analytical Files to identify men aged ≥65 years who underwent PP implantation between 2018 and 2021. Surgeon volume data were obtained from the Atlas All-Payor Claims dataset, and quartiles were calculated. Multivariable logistic regression was used to evaluate associations between reoperation rates, patient characteristics, and surgeon volume.</p><p><strong>Outcomes: </strong>The reoperation rate at 1-year post-implantation, the cause of reoperation, and factors associated with a higher reoperation rate.</p><p><strong>Results: </strong>Among 8343 patients, 2.3% required reoperation at 90 days and 6.3% at 1 year. The most common comorbidities were diabetes (35.2%), cardiovascular disease (23.9%), Peyronie's disease (15.4%), and obesity (11.5%). Surgeon volume quartiles were calculated, with the highest-volume surgeons performing >31 cases annually versus <6 for the lowest quartile. Lower surgeon volume, older patient age, and smoking were associated with higher reoperation rates. Patients treated by top-quartile surgeons had 25%-28% lower odds of reoperation at 1 year [OR 0.72; 95% CI 0.56-0.93; OR 0.75; 95% CI 0.59-0.97].</p><p><strong>Clinical implications: </strong>While higher surgeon volume was associated with lower reoperation rates, PP surgery remained safe across all volume levels.</p><p><strong>Strengths and limitations: </strong>Strengths include the use of a nationally representative Medicare dataset and All-Payor volume-outcome analysis. Limitations include accuracy of claims data, inability to fully characterize reoperations, and lack of data for procedures performed in ambulatory surgery centers.</p><p><strong>Conclusion: </strong>In a nationally representative Medicare cohort, PP reoperation rates were low (6.3%), with mechanical complications accounting for 41% of reoperations (2.6% of the cohort). Higher-volume surgeons had lower reoperation rates, but outcomes remained acceptable across all volume levels, reinforcing the overall safety of the procedure.</p>","PeriodicalId":51100,"journal":{"name":"Journal of Sexual Medicine","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Sexual Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jsxmed/qdaf064","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Prior studies have examined patient-specific predictors of reoperation following penile prosthesis (PP) insertion at the local and regional level, but little is known about patient factors and volume-outcome relationships at the national level.
Aim: To assess the impact of patient characteristics and surgeon volume on reoperation rates following PP placement in a Medicare population.
Methods: We utilized the 100% Medicare Standard Analytical Files to identify men aged ≥65 years who underwent PP implantation between 2018 and 2021. Surgeon volume data were obtained from the Atlas All-Payor Claims dataset, and quartiles were calculated. Multivariable logistic regression was used to evaluate associations between reoperation rates, patient characteristics, and surgeon volume.
Outcomes: The reoperation rate at 1-year post-implantation, the cause of reoperation, and factors associated with a higher reoperation rate.
Results: Among 8343 patients, 2.3% required reoperation at 90 days and 6.3% at 1 year. The most common comorbidities were diabetes (35.2%), cardiovascular disease (23.9%), Peyronie's disease (15.4%), and obesity (11.5%). Surgeon volume quartiles were calculated, with the highest-volume surgeons performing >31 cases annually versus <6 for the lowest quartile. Lower surgeon volume, older patient age, and smoking were associated with higher reoperation rates. Patients treated by top-quartile surgeons had 25%-28% lower odds of reoperation at 1 year [OR 0.72; 95% CI 0.56-0.93; OR 0.75; 95% CI 0.59-0.97].
Clinical implications: While higher surgeon volume was associated with lower reoperation rates, PP surgery remained safe across all volume levels.
Strengths and limitations: Strengths include the use of a nationally representative Medicare dataset and All-Payor volume-outcome analysis. Limitations include accuracy of claims data, inability to fully characterize reoperations, and lack of data for procedures performed in ambulatory surgery centers.
Conclusion: In a nationally representative Medicare cohort, PP reoperation rates were low (6.3%), with mechanical complications accounting for 41% of reoperations (2.6% of the cohort). Higher-volume surgeons had lower reoperation rates, but outcomes remained acceptable across all volume levels, reinforcing the overall safety of the procedure.
期刊介绍:
The Journal of Sexual Medicine publishes multidisciplinary basic science and clinical research to define and understand the scientific basis of male, female, and couples sexual function and dysfunction. As an official journal of the International Society for Sexual Medicine and the International Society for the Study of Women''s Sexual Health, it provides healthcare professionals in sexual medicine with essential educational content and promotes the exchange of scientific information generated from experimental and clinical research.
The Journal of Sexual Medicine includes basic science and clinical research studies in the psychologic and biologic aspects of male, female, and couples sexual function and dysfunction, and highlights new observations and research, results with innovative treatments and all other topics relevant to clinical sexual medicine.
The objective of The Journal of Sexual Medicine is to serve as an interdisciplinary forum to integrate the exchange among disciplines concerned with the whole field of human sexuality. The journal accomplishes this objective by publishing original articles, as well as other scientific and educational documents that support the mission of the International Society for Sexual Medicine.